The mechanisms underlying trigeminal pain conditions are incompletely understood. In vitro animal studies have elucidated various targets for pharmacological intervention; however, a lack of clinical models that allow evaluation of viable innervated human tissue has impeded successful translation of many preclinical findings into clinical therapeutics. Therefore, we developed and characterized an in vitro method that evaluates the responsiveness of isolated human nociceptors by measuring basal and stimulated release of neuropeptides from collected dental pulp biopsies. Informed consent was obtained from patients presenting for extraction of normal wisdom teeth. Patients were anesthetized using nerve block injection, teeth were extracted and bisected, and pulp was removed and superfused in vitro. Basal and capsaicin-evoked peripheral release of immunoreactive calcitonin gene-related peptide (iCGRP) was analyzed by enzyme immunoassay. The presence of nociceptive markers within neurons of the dental pulp was characterized using confocal microscopy. Capsaicin increased the release of iCGRP from dental pulp biopsies in a concentration-dependent manner. Stimulated release was dependent on extracellular calcium, reversed by a TRPV1 receptor antagonist, and desensitized acutely (tachyphylaxis) and pharmacologically by pretreatment with capsaicin. Superfusion with phorbol 12-myristate 13-acetate (PMA) increased basal and stimulated release, whereas PGE 2 augmented only basal release. Compared with vehicle treatment, pretreatment with PGE 2 induced competence for DAMGO to inhibit capsaicin-stimulated iCGRP release, similar to observations in animal models where inflammatory mediators induce competence for opioid inhibition. These results indicate that the release of iCGRP from human dental pulp provides a novel tool to determine the effects of pharmacological compounds on human nociceptor sensitivity.
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Introduction
Although acute and chronic pain disorders involving the trigeminal system afflict literally millions of patients [53] , the precise mechanisms for many of these pain conditions and targets for effective therapeutics remain incompletely understood. Various pain signal transduction cascades have been elucidated in trigeminal neurons using very elegant in vitro animal studies; however, the translation of these findings into diagnostic and pharmacological tools in the clinic has been limited by the paucity of clinical models which allow extraction of viable innervated tissue from humans.
Human dental pulp is composed of multiple cell types, including but not limited to odontoblasts, fibroblasts, inflammatory cells, vascular cells, and sensory and sympathetic neurons. The pulp is innervated densely by unmyelinated C fibers and lightly myelinated Ad-fibers, both of which contain the putative nociceptive neuropeptides, substance P (SP) and calcitonin gene-related peptide (CGRP) [11, 13, 14, 51, 77] . Noxious mechanical and thermal stimulation, as well as chemical activation of sensory neurons, evokes peripheral and central release of SP and CGRP [34, 40, 48, 50, 59 ], while treatment with antagonists to the receptors for SP and CGRP attenuates capsaicin-evoked allodynia [25, 74] . These findings suggest that the release of SP and/or CGRP from sensory nerve terminals is a physiological indicator of nociceptive signaling and can be used to determine the effects of inflammatory mediators and pharmacological agents on the basal and stimulated activity of sensory neurons in vitro. A subclass of peptide-containing sensory neurons innervating the dental pulp also express the transient receptor potential channel type 1 (TRPV1), a ligand-gated ion channel activated by capsaicin, the pungent ingredient in chili peppers, which also mediates neuronal activation by other chemical and thermal stimuli [1, 83] .
In the present study, we hypothesized that the release of neuropeptides from human dental pulp can serve as an in vitro model 
